5-Amino-1MQ is studied in laboratory enzyme assays involving NNMT inhibition, methyl metabolism, and NAD+-associated metabolic pathways.
- NNMT enzyme assays
- Methyl metabolism
- NAD+-associated pathways
5-Amino-1MQ is an enzyme-inhibitor listing, not a peptide
It is studied in NNMT enzyme assays and NAD+-associated metabolic pathways. It is not MOTS-C and it is not the NAD+ vial.
Task 7542, batch 5-amino-50, November 9, 2025, prints 5-Amino-1-methylquinolinium 53.85 mg. No purity percent. Do not invent one.
Label and price
The catalog amount is 50 mg at $54.99. The report's mass is 53.85 mg.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
5-Amino-1MQ 50 mg research questions
Does task 7542 show purity?
No. It prints 53.85 mg and no purity percent.
Is this a peptide?
It is sold here as its own research compound, not as one of the peptide sequences.
References and further reading
- PubMed literature index — 5-Amino-1MQ 50 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.